|
2024
|
P/S
|
vaccines for human use. |
|
|
P/S
|
Vaccines for human use. |
|
|
P/S
|
Vaccines for human use |
|
|
P/S
|
Vaccines for human use |
|
|
Invention
|
Nucleic acid vaccines.
The invention relates to compositions and methods for the preparation, ma... |
|
|
Invention
|
Combination hmpv/rsv rna vaccines.
The disclosure relates to ribonucleic acid (RNA) vaccines and... |
|
|
Invention
|
Modified polynucleotides for the production of biologics and proteins associated with human disea... |
|
|
Invention
|
Sars-cov-2 t cell vaccines. Some aspects of the disclosure relate to mRNA vaccines encoding chime... |
|
|
Invention
|
Compounds and compositions for delivery of therapeutic agents. The disclosure features novel lipi... |
|
|
Invention
|
Stabilized flavivirus vaccines. Provided herein are engineered flavivirus heterotetrameric protei... |
|
|
Invention
|
Polynucleotides encoding cystic fibrosis transmembrane conductance regulator for the treatment of... |
|
|
Invention
|
Tropical disease vaccines.
The disclosure relates to tropical diseases such as viral mosquito bo... |
|
|
Invention
|
Modified polynucleotides for the production of proteins associated with human disease.
The inven... |
|
|
Invention
|
Lyme disease vaccines. This disclosure provides methods and compositions related to messenger rib... |
|
|
Invention
|
Circular mrna and production thereof. in vitro in vitro transcription using a reaction mixture in... |
|
|
Invention
|
Nucleic acid molecules encoding bi-specific secreted engagers and uses thereof. Described herein ... |
|
|
Invention
|
Anti-cd38, anti-bcma, anti-gprc5d, and anti-fcrh5 antibodies and uses to treat various diseases s... |
|
|
Invention
|
Peg targeting compounds for delivery of therapeutics. Provided herein are targeting compounds (e.... |
|
|
Invention
|
Cd16-binding antibodies and uses thereof. Described herein are CD16 singe domain antibodies and b... |
|
|
Invention
|
Polynucleotides encoding relaxin for the treatment of heart failure. This disclosure relates to m... |
|
|
Invention
|
Nucleic acid influenza vaccines and respiratory virus combination vaccines. e.g.e.g.e.g.e.g.e.g.e... |
|
|
Invention
|
Lipid nanoparticles and polynucleotides encoding galactose-1-phosphate uridylyltransferase (galt)... |
|
|
Invention
|
Compositions of mrna-encoded il-15 fusion proteins and methods of use thereof for treating cancer... |
|
|
Invention
|
Epstein-barr virus mrna vaccines. The disclosure provides mRNA vaccines for treating or preventin... |
|
|
Invention
|
Rsv rna vaccines.
The disclosure relates to respiratory syncytial virus (RSV) ribonucleic acid (... |
|
2023
|
Invention
|
Modified polynucleotides for the production of secreted proteins.
The invention relates to compo... |
|
|
Invention
|
Combination hmpv/rsv rna vaccines.
The disclosure relates to respiratory virus ribonucleic acid ... |
|
|
Invention
|
Polyribonucleotides containing reduced uracil content and uses thereof.
The invention related to... |
|
2022
|
Invention
|
Methods of purifying dna for gene synthesis.
Provided herein are methods of purifying nucleic ac... |
|
|
Invention
|
Markerless dna production.
Provided herein are genetically modified microorganisms comprising a ... |
|
|
Invention
|
Polynucleotides encoding relaxin for the treatment of fibrosis and/or cardiovascular disease.
Th... |
|
|
Invention
|
Multicolumn chromatography mrna purification.
Described herein are methods of purifying nucleic ... |
|
|
Invention
|
Mrnas encoding chimeric metabolic reprogramming polypeptides and uses thereof.
The disclosure fe... |
|
|
Invention
|
Processes for preparing lipid nanoparticle compositions for the delivery of payload molecules to ... |
|
|
Invention
|
Processes for preparing lipid nanoparticle compositions.
Provided are empty lipid nanoparticle c... |
|
|
Invention
|
Polynucleotides encoding propionyl-coa carboxylase alpha and beta subunits for the treatment of p... |
|
|
Invention
|
Pan-human coronavirus vaccines.
The disclosure relates to pan human coronavirus ribonucleic acid... |
|
|
Invention
|
Pan-human coronavirus domain vaccines.
The disclosure relates to pan human coronavirus ribonucle... |
|
|
Invention
|
Polynucleotides encoding uridine diphosphate glycosyltransferase 1 family, polypeptide a1 for the... |
|
|
Invention
|
Engineered polynucleotides for cell-type or microenvironment-specific expression.
The disclosure... |
|
|
Invention
|
Coronavirus glycosylation variant vaccines.
The disclosure provides SARS-CoV-2 mRNA vaccines, co... |
|
|
Invention
|
Mrna vaccines encoding flexible coronavirus spike proteins.
The disclosure provides mRNA vaccine... |
|
|
Invention
|
Polynucleotides encoding methylmalonyl-coa mutase for the treatment of methylmalonic acidemia.
T... |
|
|
Invention
|
Methods of monitoring in vitro transcription of mrna and/or post-in vitro transcription processes... |
|
|
Invention
|
Non-viral delivery of dna for prolonged polypeptide expression in vivo.
The compositions and met... |
|
|
Invention
|
Synthesis of trinucleotide and tetranucleotide caps for mrna production.
Provided herein are met... |
|
|
Invention
|
Therapeutic use of sars-cov-2 mrna domain vaccines.
The disclosure describes coronavirus ribonuc... |
